- Home
- ML vs KALV Comparison
ML vs KALV Comparison
Compare ML & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ML
- KALV
- Stock Information
- Founded
- ML 2013
- KALV N/A
- Country
- ML United States
- KALV United States
- Employees
- ML N/A
- KALV N/A
- Industry
- ML Retail: Computer Software & Peripheral Equipment
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- ML Technology
- KALV Health Care
- Exchange
- ML Nasdaq
- KALV Nasdaq
- Market Cap
- ML 482.3M
- KALV 523.1M
- IPO Year
- ML N/A
- KALV N/A
- Fundamental
- Price
- ML $78.89
- KALV $9.49
- Analyst Decision
- ML Strong Buy
- KALV Strong Buy
- Analyst Count
- ML 7
- KALV 4
- Target Price
- ML $96.17
- KALV $29.00
- AVG Volume (30 Days)
- ML 249.5K
- KALV 338.6K
- Earning Date
- ML 11-07-2024
- KALV 12-05-2024
- Dividend Yield
- ML N/A
- KALV N/A
- EPS Growth
- ML N/A
- KALV N/A
- EPS
- ML 0.28
- KALV N/A
- Revenue
- ML $500,281,000.00
- KALV N/A
- Revenue This Year
- ML $29.31
- KALV N/A
- Revenue Next Year
- ML $21.37
- KALV $179.39
- P/E Ratio
- ML $286.93
- KALV N/A
- Revenue Growth
- ML 23.40
- KALV N/A
- 52 Week Low
- ML $31.42
- KALV $7.39
- 52 Week High
- ML $106.82
- KALV $16.88
- Technical
- Relative Strength Index (RSI)
- ML 74.50
- KALV 33.65
- Support Level
- ML $44.23
- KALV $10.78
- Resistance Level
- ML $90.55
- KALV $11.62
- Average True Range (ATR)
- ML 5.73
- KALV 0.79
- MACD
- ML 3.22
- KALV -0.20
- Stochastic Oscillator
- ML 75.93
- KALV 4.27
About ML MoneyLion Inc.
MoneyLion Inc is a mobile banking and financial membership platform that empowers people to take control of their finances. It is a full-service digital platform to deliver mobile banking, lending, and investment solutions. The company offers a personalized, all-in-one, digital financial platform that provides convenient, low-cost access to banking, borrowing, and investing solutions tailored for its customers, rooted in data, and delivered through its proprietary technology platform.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.